Sign inJoin waitlistJoin the waitlist

Avnesh Thakor

Director, IRIS · Stanford Univ Sch of Med

Credentials: · · · · ·

History

University of Toronto (2015) Canada
2014–2015
University of Toronto (2015) Canada
2010–2015
University of British Columbia
2013–2014
University of British Columbia
2010–2014
Preliminary Pediatrics
Stanford Health Care
2006–2007
University of London, Cancer Therapeutics
School of Clinical Medicine, University of Cambridge
2002–2006
University of Cambridge, Physiology
1998–2002

Research

Mesenchymal Stromal Cell Homing: Mechanisms and Strategies for Improvement
Review · iScience · 2019 · Last of 3 authors · Corresponding · 433 citations
Nanooncology: the future of cancer diagnosis and therapy
Review · Current Anthropology · 2013 · First of 2 authors · 371 citations
Gold nanoparticles: a revival in precious metal administration to patients
Nano Letters · 2011 · First of 5 authors · 262 citations

Waldo Concepcion
11 papers
SL
Steven Levitte
9 papers · 8 as a fellow
DL
Daniel Liu
7 papers
Sanjiv Gambhir
7 papers
Matthew Lungren
5 papers
Everett Meyer
4 papers
Melika Rezaee
4 papers
Tarik Massoud
4 papers
Allison Pribnow
3 papers
Anne Cahill
3 papers
Ashok Theruvath
3 papers
Heike Daldrup-Link
3 papers

Grants

Treating Kidney Injury Using Soundwaves Combined with Mesenchymal Stem Cells and Their Extracellular Vesicles
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.8M · Stanford University
2021–2030
Facilitating Islet Implantation and Engraftment Following Transplantation Using Primed Umbilical Cord Mesenchymal Stem Therapies and Focused Ultrasound
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.5M · Stanford University
2025–2030
A Stem Cell Activated Cryogel Bioscaffold That Restores Islet Bioenergetics While Providing Oxygen and Nutrients at Extravascular Sites of Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $2.8M · Stanford University
2022–2027
CRISPR-Cas Editing as a Genetic Cure for Autosomal Dominant Polycystic Kidney Disease
National Institute of Diabetes and Digestive and Kidney Diseases · R41
PI · $325K · Nephrogen Inc.
2023–2025

Clinical trials

High Dose Steroid Therapy to Treat Flares in Patients With Inflammatory Bowel Disease (IBD)
Principal investigator · Completed · Phase 1
Stanford University
2022–2024